Lipid accumulation and interstitial lung disease associated with amikacin liposomal inhalation suspension in patients with Mycobacterium avium complex lung disease: a single-center retrospective cohort study

Abstract Background Amikacin liposomal inhalation suspension (ALIS), an inhaled aminoglycoside, can effectively treat refractory or relapsed Mycobacterium avium complex lung disease (MAC-LD). However, ALIS is associated with interstitial lung disease (ILD), and underlying pathological mechanisms are...

詳細記述

書誌詳細

主要な著者:	Hiroki Wakabayashi, Kazutoshi Isobe, Nobuyuki Hiruta, Shusuke Kasuya, Atsushi Sano, Yasuo Matsuzawa
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2026-03-01
シリーズ:	BMC Pulmonary Medicine
主題:	Amikacin Bronchoalveolar lavage Drug-induced interstitial lung disease Exogenous lipoid Lipoid pneumonia Mycobacterium avium complex
オンライン･アクセス:	https://doi.org/10.1186/s12890-026-04213-2
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!